Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT05325151
Eligibility Criteria:
Inclusion Criteria:
* Being female.
* Ages 30-64.
* Being an Ohio State University (OSU) patient who uses MyChart.
* Undergoing routine screening mammography.
* Normal BI-RADS1.
* At elevated breast cancer risk by the Cancer Risk Assessment (CRA) tool.
* Able to read and speak English.
* Provide consent.
Exclusion Criteria:
* Previous genetic counseling.
* Previous genetic testing for cancer risk or known mutation in a breast cancer gene: ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, PTEN, TP53.
* Previous diagnosis of breast or ovarian cancer or personal history of lobular carcinoma in situ (LCIS) or breast hyperplasia (with or without atypia).
* Being a member of a focus group that assisted with the development of the intervention.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
30 Years
Maximum Age:
64 Years
Study:
NCT05325151
Study Brief:
Protocol Section:
NCT05325151